| #122 |
M. Selim Ünlü |
Boston University |
2 |
| #122 |
Christopher Salthouse |
Nanoear Corporation |
2 |
| #122 |
Vitaliy G. Yurchenko |
Ibasis |
2 |
| #122 |
Irina Polkovnikov |
— |
2 |
| #122 |
Randall M. Erb |
Northwestern University |
2 |
| #122 |
Samuel Moskowitz |
Vertex Pharmaceuticals Incorporated |
2 |
| #122 |
Bruce M. Spiegelman |
Dana-Farber Cancer Institute |
2 |
| #122 |
Jian Li |
Xi'An Zhongxing New Software Co. |
2 |
| #122 |
Sivan Elloul |
Rubius Therapeutics |
2 |
| #122 |
Francine Gregoire |
Metabolex |
2 |
| #122 |
Sandra L. Kogan |
IBM |
2 |
| #122 |
Joon Jung |
Cyclerion Therapeutics |
2 |
| #122 |
Andrew D. Dominijanni |
Bose |
2 |
| #122 |
Jay Rodney Walton |
Qualcomm |
2 |
| #122 |
Evan Costa |
Interscope |
2 |
| #122 |
Akintunde I. Akinwande |
MIT |
2 |
| #122 |
Xuri Gao |
Enanta Pharmaceuticals |
2 |
| #122 |
Reza Abdi |
Brigham and Women's Hospital |
2 |
| #122 |
Joanne Kamens |
Rxi Pharmaceuticals |
2 |
| #122 |
Yaron Rachlin |
Draper Laboratory |
2 |
| #122 |
William N. Haining |
Dana-Farber Cancer Institute |
2 |
| #122 |
Semyon Kogan |
Colgate-Palmolive |
2 |
| #122 |
Wolfgang Fraunhofer |
AbbVie |
2 |
| #122 |
Laurence S. Gillick |
Dragon Systems |
2 |
| #122 |
Peter Watkins |
Exagrid Systems |
2 |
| #122 |
Ana L. Lattes |
E Ink Holdings |
2 |
| #122 |
Matthew C. Ebbs |
Rai Strategic Holdings |
2 |
| #122 |
David Lerner |
— |
2 |
| #122 |
Albert Chun-Chi Chin |
Hologic |
2 |
| #122 |
Samuel Ross Madden |
Cambridge Mobile Telematics |
2 |
| #122 |
Phillip A. Sharp |
MIT |
2 |
| #122 |
Jahir Pabon |
Schlumberger Technology |
2 |
| #122 |
Daniel Elbaum |
Ra Pharmaceuticals |
2 |
| #122 |
Jason Katz |
Merck |
2 |
| #122 |
Alexey L. Margolin |
Alcresta Therapeutics |
2 |
| #122 |
Anatoly Gorshechnikov |
Neurala |
2 |
| #122 |
Jason Yap |
O2Cool |
2 |
| #122 |
Lijuan Jiang |
Chio Kang Medical |
2 |
| #122 |
Xinyuan Wu |
Hydra Biosciences |
2 |
| #122 |
Jianmin Gao |
Jiangsu University |
2 |
| #122 |
Mark J. Cartwright |
Harvard University |
2 |
| #122 |
Devavrat Shah |
MIT |
2 |
| #122 |
Vladimir Shtokman |
Akamai Technologies |
2 |
| #122 |
Martin Hurlimann |
Schlumberger Technology |
2 |
| #122 |
Aidan Rose |
Berkshire Grey Operating Company |
2 |
| #122 |
Himanshu Bhat |
Siemens Healthcare Limited |
2 |
| #122 |
Glenn S. Benson |
JPMorgan Chase |
2 |
| #122 |
Paul S. Palumbo |
Cabot |
2 |
| #122 |
Heung Chuan Lam |
Netbio |
2 |
| #122 |
Omid C. Farokhzad |
Brigham and Women's Hospital |
2 |